Description

Legend Biotech is seeking a Sr. Director, U.S. Marketing as part of the Marketing team based in Somerset, NJ.

Role Overview

The Sr. Director, U.S. Marketing will play a pivotal role in delivering the promise of CARVYKTI to Multiple Myeloma patients in the U.S. market. This position will be responsible for leading US marketing strategy, collaborating with Legend's commercial partner Johnson & Johnson on various aspects of brand development, launch preparedness, and execution. The role will serve as the primary U.S. marketing point for Carvykti at Legend, building core marketing capabilities in cell therapy across US market. This position will be based in Bridgewater, NJ.

Key Responsibilities

• Develop and execute comprehensive US marketing strategy for CARVYKTI.
• Lead a team of marketers to support CARVYKTI adoption in 2L+ relapsed, refractory multiple myeloma across US market.
• Maximize commercial potential and drive post-launch brand performance in U.S.
• Create, implement, and monitor key performance indicators for U.S.
• Prepare market conditions for rapid product adoption of new indications.
• Collaborate with commercial analytics team to derive market insights, identify key business questions, and understand market dynamics to continuously improve marketing strategies.
• Foster strong partnerships with Legend/Johnson & Johnson U.S. commercial teams to share best practices and ensure alignment.
• Work collaboratively across cross-functional leadership teams, including sales, external engagement, market access, and commercial operations.
• Engage appropriately with legal, compliance and regulatory partners, demonstrating a thorough understanding of U.S. regulatory and commercial compliance environments.
• Develop and deliver high-impact presentations to senior management and other internal/external stakeholders.
• Drive innovation in marketing approaches and tactics to maintain CARVYKTI's competitive edge in the rapidly evolving cell therapy market.
• Develop and implement comprehensive KOL engagement plans aligned with Carvykti's market positioning and growth objectives.
• Establish and nurture strong, collaborative relationships with key opinion leaders (KOLs) in the oncology and CAR-T cell therapy fields across the U.S.
• Create a robust network of influential Carvykti advocates within the medical community.

Requirements

• BA/BS required; MBA strongly preferred.
• Extensive US marketing experience with a proven track record of successfully managing large brands required.
• Strong scientific background with deep knowledge of Hematology/Oncology; experience with CAR-T/cellular therapy strongly preferred.
• Demonstrated initiative, creativity, strategic capabilities, and ability to work effectively in complex, rapidly changing global environments.
• Ability to conceptualize and articulate a vision for the brand that energizes all functional areas and stakeholders across regions.
• Minimum of 15+ years of industry experience, including 7+ years of oncology/hematology sales & marketing experience, with demonstrable global exposure.
• Proven ability to think strategically, align stakeholders, and drive performance in diverse markets.
• Exceptional communication skills with a track record of delivering complex messages to various internal and external customers through influential presentations.
• Experience in building and leading high-performing, diverse teams across multiple geographies.
• Strong business acumen with the ability to navigate complex organizational structures and drive results in matrix environments.
• Adaptability and resilience to thrive in a fast-paced, evolving therapeutic area.

#Li-JK1

#Li-Hybrid

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.

Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.

Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.

EEO Statement

It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.

Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.

For information related to our privacy policy, please review: Legend Biotech Privacy Policy.